|  | Collecting Quality Data in Psychiatric Trials Understanding interactions among the many factors that give rise to mental illness is a complex task. Learn how to identify and mitigate these elements early on to help ensure trial data accurately captures your compound’s safety and efficacy potential. Premier Research. Built for BiotechSM |
Today's Rundown Featured Story | | | Wednesday, March 25, 2020 Although Moderna’s COVID-19 vaccine is at least a year away from a widespread rollout, the company may provide the vaccine to a few people, which could include healthcare workers, as early as this fall. It could do so under an emergency use provision from the FDA. |
|
|---|
|
|  | Metabolon reveals a new ally for drug research and development programs. Learn more. |
Top Stories Wednesday, March 25, 2020 When Vir Biotechnology won the Fierce 15 award a few years back, infectious disease work was something of an outlier in life science R&D. But the company was adamant it was a clear and present danger to the world and one that needed addressing. Wednesday, March 25, 2020 AstraZeneca is set to pay Silence Therapeutics $60 million (€55 million) to work on siRNA therapies against cardiovascular, renal, metabolic and respiratory disease targets. The upfront cash fee is part of a suite of payments that could see Silence reel in billions of dollars through the deal. Wednesday, March 25, 2020 Kallyope set out in 2015 with $44 million and a mission to map out the “information highway” between the gut and the brain. Four years later, the company is gearing up to take its first program into the clinic, and it’s bagged $112 million to do so. Wednesday, March 25, 2020 Redpin Therapeutics has raised $15.5 million to bankroll chemogenetic R&D. The initial close of the series A positions Redpin to move a controllable gene therapy for the treatment of indications such as epilepsy and pain toward an IND. Wednesday, March 25, 2020 While all the rage seems to be focused on cell and gene therapies these days, Shanghai-based biotech Laekna still believes in the power of checkpoint inhibitors. Tuesday, March 24, 2020 Ford Motor Company has outlined plans to re-task some of its manufacturing lines toward the production of much-needed medical equipment including protective face masks, personal air-filtering equipment and ventilator systems for intensive care units. Wednesday, March 25, 2020 After earning an FDA nod for breast cancer in December four months ahead of schedule, AstraZeneca and Daiichi Sankyo’s HER2-targeting antibody-drug conjugate Enhertu is showing some early promise in a phase 1 trial in other cancer types. The antibody-drug conjugate produced a 55.6% objective response rate in HER2-positive non-small cell lung cancer patients. Enrollment Showcase | | | Presented by: Global EMBA for Healthcare & the Life Sciences, University of Toronto Prepare to step up in your career, build the expertise you need to reshape your organization, and explore opportunities worldwide. |
|
|---|
|
Resources Sponsored by: Outer Edge Technology To survive in these challenging conditions, companies need to promptly address business continuity issues - especially the remote delivery of data and voice solutions. See how Outer Edge can help. Sponsored by: Patheon, by Thermo Fisher Scientific Poorly soluble molecules hindering your workflow? Sponsored by: eClinical Solutions Key findings from the 2019 Life Sciences Data & Analytics Survey conducted by the Tufts Center for the Study of Drug Development will be unveiled during this live webinar led by industry expert and study lead, Ken Getz, Director of Sponsored Programs and Associate Professor. Sponsored by: Catalent Learn how to drive excellence within the forecasting process and utilize forecasting throughout the clinical study to better plan clinical supply budgets and project timelines. Explore how to identify potential supply-related issues before they can negatively impact your study. Sponsored by: Catalent Whether a study is simple or highly complex, forecasting and simulation reports serve as data driven communication tools to help minimize risks and keep the study on track. Learn more about forecasting solutions for informed decision making and supporting contingency planning for clinical study. Sponsored by: Catalent Learn about a real-world example of how clinical supply management expertise was applied to overcome inventory challenges for a complex, global study. Sponsored by: Outer Edge Technology See why innovative BioPharma’s are partnering with Cloud Service Provider’s to design, manage and implement cloud strategies to smooth the path to FDA approval and enhance their competitive prowess. Sponsored by: Metabolon Metabolomics can help you streamline your drug development process by providing the framework to make a stronger, more confident, and more valuable case for a molecule in a shorter timeframe. Sponsored by: Epsilon Download this e-book to learn 9 ways to enhance the customer experience within healthcare marketing. Sponsored by: Reprints Desk/Research Solutions 3 ways you may be overspending on scientific literature access, and how to fix them. Sponsored by: Baxter When different drug products are produced in shared facilities, potential for cross-contamination needs to be addressed. Outsourcing to a CMO with experience in multiproduct facilities can be an option. Sponsored by: WCG Metrics Champion Consortium Ineffective measurement could mean wasting both time and money. This whitepaper showcases a custom-built Metric Maturity Model that helps illustrate and define the process for measuring the right things the right way. Sponsored by: The Kinetix Group Read about the innovative ways payers are making smart moves in the healthcare game. Sponsored by: Catalent This whitepaper discusses the benefits of end-to-end solutions and share case studies on how flexible manufacturing strategies can accommodate the changing landscape of pharmaceutical products and help bring a drug to market. Sponsored by: Catalent Get expert insights on strategies to implement flexible manufacturing and different technologies that are easily scalable and reproducible. Sponsored by: Catalent Regardless of the assigned FDA expedited approval designation and approach, the key action items should be: the assurance of a detail-oriented plan and the adaption of a “forward-thinking” approach that will assist in any future challenges and opportunities for growth of each project. | 
